|
Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
|
April 6, 2024
|
PC3I Authors Melina Marmarelis; Peter Gabriel; Charu Aggarwal |
Clinical Lung Cancer
|
|
Ovarian Cancer Isn’t Just a White Woman’s Disease
|
April 4, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
JAMA Oncology
|
|
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research
|
April 4, 2024
|
PC3I Authors Alix Seif; Allison Barz Leahy |
Cancer Medicine
|
|
Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials
|
April 3, 2024
|
PC3I Authors Efrat Dotan |
NEJM Evidence
|
|
Prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey
|
April 2, 2024
|
PC3I Authors Daniel Lee |
Urology Practice
|
|
National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data
|
April 2, 2024
|
PC3I Authors Larry Shulman |
Journal of Clinical Oncology
|
|
Reply by Authors
|
April 1, 2024
|
PC3I Authors Daniel Lee |
Urology practice
|
|
Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study
|
March 30, 2024
|
PC3I Authors Surbhi Grover |
BMC Women's Health
|
|
Uses and limitations of artificial intelligence for oncology
|
March 30, 2024
|
PC3I Authors Likhitha Kolla |
Cancer
|
|
Immunohistochemistry-based detection of TP53 mutations in acute myeloid leukemia: a promising high sensitivity diagnostic approach
|
March 27, 2024
|
PC3I Authors Catherine Lai |
Leukemia & Lymphoma
|
|
Usability testing of a mobile health application to support individuals with active tuberculosis: a mixed methods study
|
March 26, 2024
|
PC3I Authors George Demiris |
Informatics for Health & Social Care
|
|
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana
|
March 26, 2024
|
PC3I Authors Surbhi Grover |
Cancer
|
|
The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia
|
March 23, 2024
|
PC3I Authors Alix Seif |
Leukemia
|
|
Real-world use, dose intensity, and adherence to enfortumab vedotin in locally advanced or metastatic urothelial cancer
|
March 19, 2024
|
PC3I Authors Ronac Mamtani |
Urologic Oncology
|
|
Hope for a Future Free of Unconscious Biases and Racial Anxiety in Cancer Care
|
March 19, 2024
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Journal of the National Comprehensive Cancer Network
|
|
Web Exclusive. Annals On Call – Real-World Complications of Lung Cancer Screening
|
March 18, 2024
|
PC3I Authors Katharine Rendle; Anil Vachani |
Annals of Internal Medicine
|
|
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?
|
March 16, 2024
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Longitudinal Pattern of Lymphedema and Fibrosis in Patients With Oral Cavity or Oropharyngeal Cancer: A Prospective Study
|
March 15, 2024
|
PC3I Authors Jie Deng |
International Journal of Radiation Oncology, Biology, Physics
|
|
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial
|
March 13, 2024
|
PC3I Authors Catherine Lai |
Cancers
|
|
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective
|
March 12, 2024
|
PC3I Authors Ronac Mamtani |
Journal of Medical Economics
|
